LI Qiuping, HAO Xiaoqing, LIU Song. Research Progress on Pharmacological Effect of Gastrointestinal Lipase Inhibitor in the Treatment of Obesity:Taking Orlistat as an Example[J]. Chinese Journal of Modern Applied Pharmacy, 2022, 39(17): 2287-2292. DOI: 10.13748/j.cnki.issn1007-7693.2022.17.020
    Citation: LI Qiuping, HAO Xiaoqing, LIU Song. Research Progress on Pharmacological Effect of Gastrointestinal Lipase Inhibitor in the Treatment of Obesity:Taking Orlistat as an Example[J]. Chinese Journal of Modern Applied Pharmacy, 2022, 39(17): 2287-2292. DOI: 10.13748/j.cnki.issn1007-7693.2022.17.020

    Research Progress on Pharmacological Effect of Gastrointestinal Lipase Inhibitor in the Treatment of Obesity:Taking Orlistat as an Example

    • Obesity is a chronic metabolic disease caused by the excess of energy in body. It may lead to the type II diabetes, cardiovascular disease, hypertension, stroke, and a variety of cancers. At present, many drugs are using for the treatment of obesity. Gastrointestinal lipase inhibitors are the most effective drugs of that. This paper reviewed the research progress of the gastrointestinal lipase inhibitors in the treatment of obesity and its representative drug orlistat, which aimed to provide references for the development of slimming drugs.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return